Profile
AXDX ABT BSX-PA BSX SYK MDT
Company Name Accelerate Diagnostics, Inc. Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $859.92K $215.17B $175.45B $153.33B $149.38B $114.81B
Employees 0.11K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Jack Phillips Robert B. Ford Michael F. Mahoney Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha
Ratings
AXDX ABT BSX-PA BSX SYK MDT
Quant Rating Score 2 1 2 3 3
Quant Rating Sell Strong Sell Sell Neutral Neutral
Trading
AXDX ABT BSX-PA BSX SYK MDT
Last Close $0.034 $123.67 $122.18 $103.64 $389.41 $89.61
High 52 $2.02 $140.22 $122.18 $107.41 $399.9 $94.5
Low 52 $0.03 $102.03 $122.18 $72.96 $315.94 $78.46
Price vs. 52 Week High -98.32 % -11.8 % 0 % -3.51 % -2.62 % -5.17 %
Price vs. 52 Week Low 13.33 % 21.21 % 0 % 42.05 % 23.25 % 14.21 %
Total Return
AXDX ABT BSX-PA BSX SYK MDT
1 Month Return 0 % -7.01 % 0 % 2.31 % 3.69 % 3.79 %
3 Month Return -93.58 % -4.79 % 0 % 10.75 % 14.63 % 9.55 %
6 Month Return -96.96 % 5.89 % 0 % 2.71 % -1.63 % 1.39 %
9 Month Return -98.16 % 5.71 % 0 % 17.71 % 6.03 % -1.56 %
YTD Return -97.17 % 9.34 % 0 % 16.03 % 8.15 % 12.18 %
1 Year Return -96.96 % 21.21 % 0 % 33.63 % 14.21 % 12.75 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AXDX ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.88 % - - 0.85 % 3.14 %
Dividend Paid and Capex Coverage Ration (TTM) -47.53 % 1.44 % 3.96 % 3.96 % 2.2 % 1.29 %
Dividend Per Share (TTM) - 2.32 % - - 3.32 % 2.81 %
Payout Ratio (TTM) - 27.93 % 1.13 % 1.13 % 43.2 % 76.97 %
Profitability
AXDX ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM 23.12 % 56.14 % 67.15 % 67.15 % 63.57 % 64.06 %
Return on Assets TTM -175.26 % 17.16 % 5.06 % 5.06 % 6.21 % 5.09 %
Return on Equity TTM 121.19 % 31.84 % 9.56 % 9.56 % 10.73 % 9.62 %
Return on Capital Employed TTM 1335.05 % 11.05 % 8.77 % 8.77 % 9.61 % 7.56 %
Net Income Per EBT TTM 99.87 % 176.99 % 81.97 % 81.97 % 85.78 % 82.85 %
EBT Per Ebit TTM 141.91 % 104.44 % 80.59 % 80.59 % 91.04 % 94.51 %
EBIT Per Revenue TTM -301.86 % 17.54 % 17.52 % 17.52 % 15.77 % 17.76 %
Cash Flow To Debt Ratio TTM -36.34 % 67.59 % 32.56 % 32.56 % 29.81 % 24.7 %
Receivables Turnover TTM 5.74 4.46 6.52 6.52 5.86 5.15
Payables Turnover TTM 1.86 4.49 5.74 5.74 - 4.74
Inventory Turnover TTM 3.15 2.85 2.01 2.01 1.66 2.12
Fixed Asset Turnover TTM 201.07 % 394.34 % 517.94 % 517.94 % 656.62 % 490.52 %
Asset Turnover TTM 40.97 % 52.93 % 43.73 % 43.73 % 50.47 % 36.58 %
Operating Cash Flow Per Share TTM -1.04 5.15 2.58 2.58 11.23 5.49
Free Cash Flow Per Share TTM -1.06 3.83 1.94 1.94 9.37 4.04
Cash Per Share TTM 69.94 % 393.83 % 49.08 % 49.08 % 631.12 % 699.13 %
Operating Cash Flow Sales Ratio TTM -206.82 % 20.76 % 21.72 % 21.72 % 18.47 % 21 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.1 % 74.38 % 75.37 % 75.37 % 83.42 % 73.61 %
Cash Flow Coverage Ratios TTM -36.34 % 67.59 % 32.56 % 32.56 % 29.81 % 24.7 %
Price To Free Cash Flows Ratio TTM -0.03 32.32 53.29 53.37 41.76 22.14
Price To Operating Cash Flows Ratio TTM -0.03 24.01 40.1 40.16 34.79 16.31
Price Cash Flow Ratio TTM -0.03 24.01 40.1 40.16 34.79 16.31
Income Statement (TTM)
AXDX ABT BSX-PA BSX SYK MDT
Revenue $0.01B $41.95B $16.75B $16.75B $22.6B $33.54B
Gross Profit $0B $23.24B $11.49B $11.49B $14.44B $21.97B
Gross Profit Ratio 23.12% 55.41% 68.61% 68.61% 63.91% 65.51%
EBITDA $-0.03B $10.83B $3.86B $3.86B $5.72B $5.96B
Net Income $-0.05B $13.4B $1.85B $1.85B $2.99B $4.66B
EPS Diluted -2.15 7.64 1.25 1.25 7.76 3.61
Balance Sheet (MRQ)
AXDX ABT BSX-PA BSX SYK MDT
Long Term Debt $0.05B $13.52B $9.37B $9.37B $12.19B $25.64B
Total Liabilities $0.08B $33.51B $17.39B $17.39B $22.34B $43.42B
Total Equity $-0.06B $47.9B $22B $22B $20.63B $48.26B
Total Investments $0B $1.24B $0.56B $0.56B $0.84B $6.75B
Total Debt $0.07B $15.02B $11.15B $11.15B $13.6B $28.52B
Total Assets $0.03B $81.41B $39.4B $39.4B $42.97B $91.68B
Cash Flow Statement (TTM)
AXDX ABT BSX-PA BSX SYK MDT
Net Income $-0.05B $13.4B $1.85B $1.85B $2.99B $4.69B
Inventory $-0B $-0.06B $-0.23B $-0.23B $0.05B $-0.29B
Dividends Paid $0B $-3.84B $0B $0B $-1.22B $-3.59B
Operating Cash Flow $-0.02B $8.56B $3.44B $3.44B $4.24B $7.04B
Capital Expenditure $0B $-2.21B $-0.79B $-0.79B $-0.76B $-1.86B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 125.005
ADGM Adagio Medical Holdings, Inc. 1.56
AEMD Aethlon Medical, Inc. 1.3104
AFIB Acutus Medical, Inc. 0.00135
AHCO AdaptHealth Corp. 9.265
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 190.96
ALUR Allurion Technologies Inc. 3.14
AMIX Autonomix Medical, Inc. Common Stock 1.8301
ANIK Anika Therapeutics, Inc. 10.805
AORT Artivion, Inc. 30.82
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 2.21
ARAY Accuray Incorporated 1.355
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 10.415
AVNS Avanos Medical, Inc. 11.405
AVR Anteris Technologies Global Corp. Common Stock 3.0386
AXGN AxoGen, Inc. 11.66
ETFs With Exposure to AXDX
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 310.76
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00004 138.08
VXF Vanguard Extended Market Index Fund 0 198.84
IWC iShares Micro-Cap ETF 0.00849 134.31
VTSAX Vanguard Total Stock Market Index Fund 0 150.5
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 150.58
VITSX Vanguard Total Stock Market Index Fund 0 150.53
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000134208 106.49
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 150.59
JKK iShares Morningstar Small-Cap Growth ETF 0.01 307.42
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
VEMPX Vanguard Extended Market Index InstlPlus 0 371.61
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 282.37
Unlock